Search - tctmd.com

Displaying 121 - 140 of 264

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Presenter: Azeem Latib

June 21, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

Presentation JIM 2018

Trialign Live in a Box

Presenter: Azeem Latib

February 24, 2018

Presentation JIM 2018

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Presenter: Azeem Latib

February 23, 2018

Presentation JIM 2018

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

Presenter: Azeem Latib

February 21, 2018

Presentation TCT 2017

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Presenter: Azeem Latib, Dean J. Kereiakes

October 31, 2017

Presentation TCT 2017

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

Presenter: Azeem Latib, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

Presenter: Azeem Latib, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

Presenter: Azeem Latib, Manel Sabate

October 31, 2017

Presentation TCT 2017

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Presenter: Azeem Latib, Joanna J. Wykrzykowska

October 31, 2017

Presentation TCT 2017

Case Presentation: My Worst Bifurcation Mistake

Presenter: Antonio Colombo, Manuel Pan, Azeem Latib

October 30, 2017

Presentation TCT 2017

Cardioband Direct Annuloplasty for Functional MR: Procedure and Tips and Tricks

Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Azeem Latib

October 30, 2017

Presentation TCT 2017

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Presenter: David Erlinge, Niels R. Holm, Azeem Latib

October 30, 2017

Presentation TCT 2017

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Presenter: Antonio Colombo, Samir R. Kapadia, Azeem Latib

October 29, 2017

Presentation TCT 2017

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

Presenter: Antonio Colombo, Azeem Latib, Jason H. Rogers

October 29, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Industry News

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

July 11, 2017

News Industry News

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

June 16, 2017

Presentation TVT 2017

Transcatheter Tricuspid Repair of Patient With Severe TR and Mitral Stenois

Presenter: Azeem Latib, Christopher U. Meduri

June 15, 2017

Advertisement

The New Syndrome of Delayed Coronary Occlusion (DCA) After TAVR: Frequency, Causes, and Outcomes

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Trialign Live in a Box

The EMBLOK Embolic Protection System Early Feasibility and Safety Study: Preliminary Results

Case: 57-year old man with known Alport syndrome: dialysis from age 17-years

What Is the Optimal DAPT Duration With ABSORB? Results From a Comprehensive Meta-Analysis

ABSORB IV 30-Day Results: Is Improved Technique Reflected in Superior Early Outcomes?

Featured Lecture: ABSORB Program 3-Year Meta-Analysis and Adjusted PSP Evaluation - Lessons Learned With a First Generation Scaffold

ABSORB II at 4 Years: Clinical Outcomes Beyond the Cusp of Complete Bioresorption

ABSORB in STEMI I: TROFI II 3-Year Clinical Outcomes and Correlations With the 6-Month OCT Findings

New Insights From AIDA: Subgroups and Predictors of Adverse Events

Case Presentation: My Worst Bifurcation Mistake

Cardioband Direct Annuloplasty for Functional MR: Procedure and Tips and Tricks

Case #1: Stent Sizing, Lesion Length Determination and Optimization by IVUS (With Discussion)

Tricuspid Valve Interventions: Patient Selection, Devices, and Predictions

Mitral Valve Interventions: MitraClip, Annular Treatments, and Valves Where Will We Be in 5 Years? In 10 Years?

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Innovative Cardiovascular Solutions Raises $5.0 Million in Series B Financing for Advanced Device Development and Initiation of U.S. Clinical Activities

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

Transcatheter Tricuspid Repair of Patient With Severe TR and Mitral Stenois

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content